• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 414937 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414771833 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414771833 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Shares of Halozyme Therapeutics Under Pressure, Down 1.3%

Published on Thu, 01/03/2013 - 11:37
By Peter Chu

Halozyme Therapeutics (NASDAQ:HALO) is one of today's notable stocks in decline, down 1.3% to $6.70. The S&P is trading fractionally lower to 1,460 and the Dow is trading 0.2% lower to 13,383.

There is potential upside of 33.3% for shares of Halozyme Therapeutics based on a current price of $6.70 and an average consensus analyst price target of $8.93. The stock should hit resistance at its 200-day moving average (MA) of $7.53, as well as support at its 50-day MA of $5.71.

Halozyme Therapeutics, Inc. develops and commercializes recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The Company's product portfolio is based on intellectual property covering the family of human enzymes known as hyaluronidases. Halozyme's products offer an alternative to slaughterhouse-derived extracts that carry contamination risks.

Over the past year, Halozyme Therapeutics has traded in a range of $3.86 to $13.50 and is now at $6.70, 74% above that low. The 200-day and 50-day moving averages have moved 1.04% lower and 0.59% higher over the past week, respectively.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Stock Investors Bid Up Shares of Thorate...

Thoratec (NASDAQ:THOR) is one of today's biggest movers, up 2.5% to $27.06. The S&P is ...

Methanex Bullish Moving Average Crossove...

Methanex (NASDAQ:MEOH) crossed over its 10-day moving average of $57.42 on a volume of ...

Highest Projected Earnings Growth in the...

Below are the three companies in the Food Distributors industry with the highest projec ...

Stock Investors Bid Up Shares of Nidec, ...

Nidec (NYSE:NJ) is one of today's notable stocks on the rise, up 2.5% to $16.50. The S ...

Trinity Industries Crosses Above its 10-...

Trinity Industries (NYSE:TRN) crossed over its 10-day moving average of $34.83 on a vol ...

Tetra Tech has the Highest Projected Ear...

Below are the three companies in the Environmental & Facilities Services industry with ...

Stock Investors Bid Up Shares of Viasat,...

Viasat (NASDAQ:VSAT) is a company whose shares are active, trading 2.5% higher to $61.8 ...

Williams-Sonoma Crosses Above its 10-day...

Williams-Sonoma (NYSE:WSM) shares have crossed bullishly above their 10-day moving aver ...